drugset / Trial / NCT04733625

The Effect of Vitamin D Therapy on Morbidity and Moratlity in Patients With SARS-CoV 2 Infection

NCT04733625

Completed 56 enrolled Kasr El Aini Hospital
RandomizedParallel-groupTriple-blindTreatment

Summary

The ongoing pandemic of SARS CoV-2 virus is calling for effective preventive and theraputic interventions. Vitamin D has been shown to play immunemodulatory functions in human. Low vitamin D levels have been linked to increased susciptability to infections especially the acute respiratory infections. This randomised controlled study aims to explore the effect of vitamin D administration on the outcome of SARS- CoV2 virus

Timeline

Start
2020-09-15
Primary completion
2020-12-17
Completion
2020-12-17

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cholecalciferol Other / unclassified 200000 iu Intramuscular

Indications